BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Nov 08, 2022 3:58pm

54 Views

Post# 35083241

BIOV SHAKE DA TREE LIKE A GAIL FORCE WINDS SHAKE IT BOTS!

ITG WORKING way over time

Recent Trades - Last 10 of 185

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:35:11	C	0.16	-0.04	100	14 Virtu ITG	7 TD Sec	E
15:35:11	C	0.16	-0.04	100	7 TD Sec	7 TD Sec	E
15:35:11	C	0.16	-0.04	7,000	124 Questrade	7 TD Sec	K
15:33:55	U	0.165	-0.035	500	2 RBC	13 Instinet	K
15:33:29	C	0.16	-0.04	200	7 TD Sec	7 TD Sec	E
15:33:29	C	0.16	-0.04	7,500	124 Questrade	7 TD Sec	K
15:33:29	C	0.16	-0.04	500	7 TD Sec	7 TD Sec	K
15:30:14	U	0.16	-0.04	500	13 Instinet	2 RBC	K
15:30:14	U	0.16	-0.04	3,500	13 Instinet	2 RBC	K
15:30:14	U	0.16	-0.04	12,000	1 Anonymous	2 RBC	K